| PWETX | RNWFX | PWETX / RNWFX | |
| Total Expense Ratio | 0.89 | 0.62 | 144% |
| Annual Report Gross Expense Ratio | 1.29 | 0.62 | 208% |
| Fund Existence | 3 years | 24 years | - |
| Gain YTD | 11.053 | 6.094 | 181% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 552M | 75.5B | 1% |
| Annual Yield % from dividends | 1.24 | 1.31 | 95% |
| Returns for 1 year | 47.29 | 27.90 | 169% |
| Returns for 3 years | N/A | 43.85 | - |
| Returns for 5 years | N/A | 12.39 | - |
| Returns for 10 years | N/A | 127.30 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AALG | 14.44 | 0.72 | +5.25% |
| Leverage Shares 2X Long Aal Daily ETF | |||
| KBE | 65.23 | 0.73 | +1.13% |
| State Street® SPDR® S&P® Bank ETF | |||
| NCZ | 14.50 | -0.02 | -0.14% |
| Virtus Convertible & Income Fund II | |||
| CPNJ | 27.10 | -0.04 | -0.15% |
| Calamos Nasdaq-100 Str Alt Prt ETF-Jun | |||
| FMED | 26.61 | -0.26 | -0.97% |
| Fidelity Disruptive Medicine ETF | |||